The 2005 Leon I. Goldberg Young Investigator Award Lecture: Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer

William D. Figg

doi:10.1016/j.clpt.2005.09.006

The 2005 Leon I. Goldberg Young Investigator Award Lecture: Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer

William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

10 Scopus citations

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Clinical Pharmacology and Therapeutics
Volume	79
Issue number	1
DOIs	https://doi.org/10.1016/j.clpt.2005.09.006
State	Published - Jan 2006
Externally published	Yes

Access to Document

10.1016/j.clpt.2005.09.006

Cite this

@article{dfa8d557ba2c43a4a553258ae9e40aa3,

title = "The 2005 Leon I. Goldberg Young Investigator Award Lecture: Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer",

author = "Figg, {William D.}",

year = "2006",

month = jan,

doi = "10.1016/j.clpt.2005.09.006",

language = "English",

volume = "79",

pages = "1--8",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

number = "1",

}

TY - JOUR

T1 - The 2005 Leon I. Goldberg Young Investigator Award Lecture

T2 - Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer

AU - Figg, William D.

PY - 2006/1

Y1 - 2006/1

UR - http://www.scopus.com/inward/record.url?scp=30344445990&partnerID=8YFLogxK

U2 - 10.1016/j.clpt.2005.09.006

DO - 10.1016/j.clpt.2005.09.006

M3 - Comment/debate

C2 - 16413236

AN - SCOPUS:30344445990

SN - 0009-9236

VL - 79

SP - 1

EP - 8

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 1

ER -

The 2005 Leon I. Goldberg Young Investigator Award Lecture: Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer

Access to Document

Fingerprint

Cite this